North America Pharmaceutical Continuous Manufacturing Market is expected to reach US$ 1,335.15 Mn by 2027

The integrated systems Segment to Grow at Faster Pace During Forecast Period

According to The Insight Partners market research study of “North America Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Product, Application and End User,” the North America pharmaceutical continuous manufacturing market is projected to reach US$ 1,335.15 million by 2027 from US$ 619.24 million in 2019. The market is estimated to grow at CAGR of 10.2% from 2020 to 2027. The report highlights trends prevailing in the North America pharmaceutical continuous manufacturing market and the factors driving market along with those that act as hindrances.

The North America pharmaceutical continuous manufacturing market, based on product, is further segmented into integrated systems, semi-continuous systems, and controls. The integrated systems segment held a larger share of the market in 2019 and, also the similar segment is estimated to register a higher CAGR during the forecast period. The system helps to complete a continuous manufacturing for R&D, which gives more possibility to understand the continuous manufacturing technology to achieve consequently, which is likely to drive the growth for pharmaceutical continuous manufacturing market during the forecast period.

The North America pharmaceutical continuous manufacturing market is expected to grow owing to advantages offered by continuous manufacturing process in the region. However, high capital investments is likely to restrain the growth of the market during the forecast period.

The number of infections of COVID-19 has killed thousands and rising exponentially. The US is one of the biggest markets for new product developments, along with the adoption of continuous pharmaceutical manufacturing in companies. Pharmaceutical supplies and procurement are also severely affected by the outbreak of COVID-19 in North America. The coronavirus disease 2019 (COVID-19) outbreak highlights potential vulnerabilities in both our drug supply chain and our clinical infrastructure, including the availability of adequate clinician resources.

Leading companies operating in the pharmaceutical continuous manufacturing market are Munson Machinery Co., Inc., THERMO FISHER SCIENTIFIC INC., GEA Group, Coperion GmbH, Gericke AG and, among others.

 North America Pharmaceutical Continuous Manufacturing Market, By Country, 2019 (%)

---

North America Pharmaceutical Continuous Manufacturing Market to Grow at a CAGR of 10.2% to reach US$ 1,335.15 Million from 2020 to 2027

Download Free Sample

---

North America Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Integrated Systems, Semi-Continuous Systems, Controls); Application (End Product Manufacturing, API Manufacturing); End User (Full-Scale Manufacturing Companies, R&D Departments); and, Country

The report segments North America Pharmaceutical Continuous Manufacturing Market as follows:

By Product

• Integrated Systems
• Semi-Continuous Systems
  • Continuous Granulators
  • Continuous Blenders
  • Continuous Compressors

  • Continuous Coaters
  • Continuous Dryers
  • Other Semi-Continuous Systems
• Controls

By Application

• End Product Manufacturing
  • Solid Dosage Manufacturing
  • Liquid Dosage Manufacturing
• API Manufacturing

By End-User

• Full Scale Manufacturing Companies
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
• R & D Departments
  • Contract Research Organizations
  • Research Institutes

By Country

• US
• Canada
• Mexico